Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Other: heart-failure related pharmaceutical intervention
- Registration Number
- NCT02149940
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Brief Summary
Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been shown to have a beneficial impact on heart failure related outcomes. Regardless, a high residual event rate is to be noted.
In our pilot study, we wished to document whether a clinical pharmacist could still play a role in the heart failure management of an elderly inpatient heart failure population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
- 75 years or older
- diagnosis of previous or new heart failure based on signs and symptoms as defined by the 'European Society of Cardiology guidelines on acute and chronic heart failure'
- diagnosis had to be confirmed by a recent echocardiogram
Exclusion Criteria
- not Dutch speaking
- treatment restrictions had been applied on admission
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description clinical pharmacy intervention heart-failure related pharmaceutical intervention -
- Primary Outcome Measures
Name Time Method the number of heart-failure related pharmaceutical interventions during hospital stay (average of 14 days)
- Secondary Outcome Measures
Name Time Method acceptance rate of the pharmaceutical interventions during hospital stay (average of 14 days) clinical feasibility of the accepted interventions during hospital stay (average of 14 days)
Trial Locations
- Locations (1)
University Hospitals Leuven
🇧🇪Leuven, Flemish Brabant, Belgium